SOA Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
SOA Wealth Advisors's ARKG Position: Q4 2025 in Review
SOA Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 155 shares — an estimated $4.3K sold.
SOA Wealth Advisors first reported a position in ARKG in Q4 2020 and held it in 20 quarters. The position peaked at $8.61M in Q4 2020. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.
- SOA Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
- SOA Wealth Advisors sold 155 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $4.3K.
- SOA Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 20 quarters.
- SOA Wealth Advisors's ARK Genomic Revolution ETF position peaked at $8.61M in Q4 2020.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.
Based on SOA Wealth Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.